secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYOMO, INC. (MYO)
CIK:        0001369290
Form:       8-K
Filed at:   2023-05-10T23:59:59+00:00
Accession:  0000950170-23-020555
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myomo Q1 product rev up 20% to $3.4M; record 438 pipeline patients added
------------------------------------------------------------------------

- Product revenue $3.4M, +20% YoY; total revenue $3.4M (-11% due to prior-year license fee).
- Record 438 new pipeline patients from previous payers (+54% YoY); total pipeline 855 (+28%).
- Cost per pipeline add $1,579 (down 53% YoY, 50% sequentially).
- Net loss $2.6M ($0.11 per share) vs $2.8M ($0.43) in Q1 2022.
- Guides 20-30% product revenue growth for 2023; cash $11M after April license fee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369290/000095017023020555/0000950170-23-020555-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369290/000095017023020555/myo-20230510.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-020555

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer